STOCK TITAN

CooperSurgical® partners with Ostro to educate consumers about Paragard® (intrauterine copper contraceptive)

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
partnership
Rhea-AI Summary

CooperSurgical has partnered with Ostro to enhance consumer engagement for its hormone-free IUD, Paragard, which prevents pregnancy for up to 10 years. This collaboration aims to provide personalized experiences on Paragard.com, featuring live Nurse Navigators to assist potential users. The partnership focuses on educating consumers about Paragard, promoting its benefits, and ensuring easier access to healthcare providers. Holly Sheffield, President of CooperSurgical, emphasizes empowering women through this initiative, while Dr. Chase Feiger, CEO of Ostro, expresses honor in collaborating on this health initiative.

Positive
  • Partnership with Ostro enhances consumer engagement for Paragard.
  • Introduction of live Nurse Navigators for personalized assistance.
  • Focus on educating consumers about contraceptive options.
Negative
  • None.

Technology partnership aims to increase engagement by educating consumers about CooperSurgical's Paragard

TRUMBULL, Conn., Dec. 14, 2022 /PRNewswire/ -- CooperSurgical, Inc., a leader in women's healthcare, and Ostro, a leading engagement platform dedicated to educating and empowering consumers and healthcare providers, today announced their partnership to launch a new consumer engagement solution for CooperSurgical's hormone-free IUD, Paragard. Paragard is an FDA-approved intrauterine device that prevents pregnancy for up to 10 years.

"By partnering with Ostro, we are truly accelerating what's possible." - Holly Sheffield, President, CooperSurgical

"CooperSurgical is dedicated to putting time on the side of women, babies, and families at the moments that matter the most in life. Patient education along with access to care is at the forefront of our mission," said Holly Sheffield, President, CooperSurgical. "By partnering with Ostro, we are truly accelerating what's possible. We are empowering women to take control of their future."

With the implementation of the Ostro technology, Paragard will now offer consumers a more personalized experience on Paragard.com that includes the option of connecting with a live Nurse Navigator who can answer questions and assist patients in determining if Paragard may be right for them. The Nurse Navigators, who are licensed healthcare professionals, can also assist patients with finding a healthcare provider in their area.

"CooperSurgical does amazing work in the field of women's healthcare," said Dr. Chase Feiger, CEO of Ostro. "It's truly an honor to have the opportunity to work with Paragard to help build consumer education and engagement around this product."

To learn more about Paragard and see the Ostro technology in action, visit Paragard.com.

Paragard is a hormone-free IUD (intrauterine device) that prevents pregnancy for up to 10 years using copper.

Important Safety Information
  • Don't use Paragard if you are or may be pregnant, have fibroids, a pelvic infection including pelvic inflammatory disease (PID), get infections easily, certain cancers, unexplained bleeding, Wilson's disease, or a copper allergy. IUDs, including Paragard, have been associated with an increased risk of PID.
  • Pregnancy with Paragard is rare but can be life threatening and cause infertility or loss of pregnancy.
  • Paragard may attach to or go through the uterus and cause other problems.
  • Tell your healthcare provider (HCP) if you develop severe pain or fever shortly after placement, miss a period, have abdominal pain, or if Paragard comes out. If it comes out, use backup birth control.
  • Tell your HCP you have Paragard before having an MRI or a medical procedure using heat therapy.
  • At first, periods may become heavier and longer with spotting in between.
  • Additional common side effects include anemia, pain during sex, backache, and vaginal discharge.
  • Paragard does not protect against HIV or STDs.

Only you and your HCP can decide if Paragard is right for you. Available by prescription only.

You are encouraged to report negative side effects of prescription drugs to the FDA at fda.gov/medwatch or call 1⁠-⁠800-FDA-1088.

Click here for the Product Information for Paragard.

About CooperSurgical

For more than 30 years, CooperSurgical has been a leader in manufacturing and marketing a wide range of trusted and innovative brands that have assisted clinicians in advancing the standard of health care for women and families worldwide. CooperSurgical is a wholly-owned subsidiary of CooperCompanies. CooperSurgical, headquartered in Trumbull, CT, produces and markets a wide array of products and services for use by women's health care clinicians. More information can be found at coopersurgical.com.

About CooperCompanies

CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies, and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of roughly 14,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.

About Ostro

Ostro was founded to help millions of people live healthier lives by creating personalized healthcare journeys that boost engagement for consumers and HCPs, and drive value for life sciences brands. The Ostro platform is composed of Ostro Navigate, a 1:1 experience that offers consumers and HCPs a personalized journey to help address their needs; Ostro Attribute, an analytics product that connects brand marketing campaigns to clinical outcomes to increase the impact of commercial spend; and Ostro Consult, a telehealth experience that supports the engagement journey by connecting patients to an experienced and qualified clinician. For more information about Ostro, visit www.ostrohealth.com.

Paragard® is a registered trademark of CooperSurgical, Inc.

© 2022 CooperSurgical, Inc. C-US-PAR-000436 October 2022

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/coopersurgical-partners-with-ostro-to-educate-consumers-about-paragard-intrauterine-copper-contraceptive-301703377.html

SOURCE Ostro

FAQ

What is the purpose of CooperSurgical's partnership with Ostro?

The partnership aims to enhance consumer engagement and education around CooperSurgical's hormone-free IUD, Paragard.

What features will Paragard.com offer after the partnership?

The website will include personalized experiences and access to live Nurse Navigators for consumer assistance.

What is Paragard?

Paragard is a hormone-free intrauterine device that prevents pregnancy for up to 10 years.

Who is the CEO of Ostro involved in the partnership with CooperSurgical?

Dr. Chase Feiger is the CEO of Ostro.

When was the partnership between CooperSurgical and Ostro announced?

The partnership was announced on December 14, 2022.

The Cooper Companies, Inc.

NASDAQ:COO

COO Rankings

COO Latest News

COO Stock Data

21.87B
198.08M
0.54%
98.32%
1.12%
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States of America
SAN RAMON